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ABSTRACT Single-copy rrn strains facilitate genetic ribosomal studies in Escherichia coli. Consecutive
markerless deletion of rrn operons resulted in slower growth upon inactivation of the fourth copy, which
was reversed by supplying transfer RNA genes encoded in rrn operons in trans. Removal of the sixth,
penultimate rrn copy led to a reduced growth rate due to limited rrn gene dosage. Whole-genome se-
quencing of variants of single-copy rrn strains revealed duplications of large stretches of genomic DNA. The
combination of selective pressure, resulting from the decreased growth rate, and the six identical remaining









The majority of antibiotic classes currently in clinical use act by
inhibiting ribosome function. Their utility is threatened by the
emergence of microbial resistance, mainly due to compound
efflux (Thaker et al. 2010), covalent modification of the ribosome
(Goossens 2009), or alteration of the antibiotic (Zhanel et al. 2012).
The binding interactions of the antibiotics with the ribosome are
established predominantly with its RNA components (Poehlsgaard
and Douthwaite 2005), which in Escherichia coli are encoded by seven
virtually identical rrn operons: rrnA through rrnH (rrnFwas renamed
as rrnG) (supporting information, Figure S1A). This sevenfold re-
dundancy limits the introduction of resistance caused by binding site
mutations, mainly due to the recessive nature of resistance mutations
that are suppressed by the presence of six wild-type alleles that lead
to rapid cell death (Orelle et al. 2013). In addition, the multiplicity of
wild-type alleles will tend to revert the mutant allele due to rapid
gene conversion. This extremely low-resistance frequency is from a
clinical perspective a very attractive feature for an antibiotic, and as a
consequence the ribosome has remained an attractive antibacterial
target despite decades of macrolide and aminoglycoside usage. From
a drug-discovery perspective, however, this redundancy makes def-
inition of a structural foundation guiding iterative chemistry pro-
grams challenging.
Onerecentexample isnegamycin, anatural compound thatmediates
its antibacterial activity by inhibition of translation (Mizuno et al. 1970)
and for which as many as 10 different ribosomal-binding sites have
been described (Schroeder et al. 2007; Olivier et al. 2014; Polikanov
et al. 2014a). The location of a single binding site through which the
compound mediated its activity, required for structure-based design of
improved analogs, remained elusive for 40 years. Negamycin-resistant
mutants of wild-type E. coli have been isolated, but the mutations
affected transport of the compound into the cell rather than binding
to the ribosome (McKinney et al. 2015). To obtain genetic evidence for
negamycin’s functional binding site, helix 34 of the small subunit, the
redundancy of wild-type E. coli ultimately needed to be circumvented
by the use of markerless single rrn strains (Olivier et al. 2014; Polikanov
et al. 2014a). Although this tool has found use in various seminal
scientific advances of ribosomal biology (Bollenbach et al. 2009; Orelle
et al. 2013; Polikanov et al. 2014b; Orelle et al. 2015), its construction
was mentioned in brief (Bollenbach et al. 2009). Here we describe the
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construction in detail, showing that sequential deletion of four rrn
genes leads to a reduced growth rate due to limiting expression of
transfer RNAs (tRNAs), and that after deletion of the sixth copy the
cellular ribosomal content becomes growth-limiting. Furthermore,
although colony morphology suggested stability of the strains
(Bollenbach et al. 2009), whole-genome analyses revealed elevated
genomic instability caused by homologous recombination between
the scars remaining upon rrn deletion.
MATERIALS AND METHODS
Supplementary Information
File S1 contains a list of strains (Table S1), a detailed rrn deletion
strategy (Figure S1, Figure S2, and Figure S3) and a map of pK4-16
(Figure S5). Additional whole-genome sequencing data are provided in
Figure S4.
Data availability
E. coli strains SQ37, SQ88, SQ2203, SQ110, and SQ171, used for ge-
nomic sequencing, were obtained from the Coli Genetic Strain Center
at Yale University. Complete nucleotide sequences of these strains have
been deposited in Genbank under accession numbers CP011320,
CP011321, CP011322, CP011323, and CP011324, respectively.
RESULTS AND DISCUSSION
A set of single rrn deletion strainswas constructed using E. coliMG1655
(Blattner et al. 1997). Seven strains, eachwith a single deletion spanning
one of the rrn operons, were made using the recombineering method
(Figure S1 and Table S1) (Datsenko andWanner 2000). Upon resolving
the kanamycin-resistance cassette from one operon, leaving a 85-bp
insertion (“scar”), we introduced a new kanamycin-resistance cassette
into another rrn operon, which was subsequently resolved, and so on
(Figure S2 and Figure S3A). Deletions of the rrn operons were con-
firmed by both polymerase chain reaction (data not shown) and South-
ern blots (Figure S3B). However, all rrn operons encode the RNA
components for the small and large ribosomal unit (rrs and rrl genes,
respectively) that are interspersed with a number of different tRNA
genes that would have prevented removal of more than five operons
(Figure S1B). Therefore, plasmid ptRNA67 (Zaporojets et al. 2003) was
introduced to provide tRNA genes of Ala-1B, Ile-1, Trp, Asp-1, Thr-1,
and Glu-2 in trans (Asai et al. 1999).
At high growth rates, as much as 70% of E. coli’s resources are
devoted to the translation machinery and protein synthesis (Russell
and Cook 1995). The ribosome forms the core of the translation
machinery and the growth rate is proportional to both cellular ribo-
some content and specific peptide elongation rate (Dennis et al.
2004). Feedback regulation is one mechanism of ribosomal RNA
regulation in E. coli. E. coli strains with a limited number of rrn
operons maintain ribosome content by increased transcription of
the remaining operons; conversely, the presence of additional rrn
copies does not change ribosome content (Gyorfy et al. 2015).
Sequential deletion of three rrn operons did not significantly alter
the doubling time of strains when grown in Luria Broth at 37, but the
additional deletion of a fourth operon resulted in an increase from 33 to
43 min (30%) [rrnGBA vs. rrnGADE P = 0.0003, rrnGBA vs. rrnGBAD
P = 0.0018 (Figure 1)]. Deletion of the fifth operon, rrnH, required the
addition of tRNA genes on a plasmid since this deletion would remove
all copies of the tRNA-Ile and tRNA-Ala genes encoded within the rrn
Figure 1 Growth rates of E. coli rrn deletion strains grown in Luria
Broth medium at 37 with and without the tRNA plasmid, ptRNA67,
and ribosomal RNA plasmid, pK4-16 (n $ 3).
Figure 2 Relative sequence read
coverage of multiple isolates of
E. coli strains SQ2203 and SQ110
and negamycin-resistant mutants de-
rived thereof (Olivier et al. 2014,
McKinney et al. 2015) reveal unsta-
ble regions of genomic duplication.
Regions that showed ~2· increased
relative coverage, reflecting duplica-
tion, are indicated with a black bar.
(A). SQ2203 yielded two variants
(blue, yellow) in additional to the
predicted, single-fold coverage ge-
nome (gray). (B) All wild-type SQ110
isolates that were sequenced con-
tained the same duplication (brown)
but different arrangements were
found among negamycin-resistant mutants. “Spikes” in the plots represent regions of homology of mainly transfer RNA and rrn genes/
operons in resident plasmids, with genomic sequences.
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operon spacers (Figure S1B). Despite the removal of the fifth operon, the
growth rate of the DrrnGADEH ptRNA67 strain was significantly higher
than that of the DrrnGADE strain, with doubling time of 38 and 43 min
respectively (P = 0.0089), suggesting that the lower growth rate of the
DrrnGADE strain was caused largely by limiting amounts of tRNA (Fig-
ure 1). This observation was confirmed by failure to increase the growth
rate of the DrrnGADE strain upon introduction of rrn encoding plasmid
pK4-16 (P = 0.87). The largest decrease in growth rate, increasing the
doubling time from 38 to 60min, was observed upon deletion of the sixth
rrn copy, leaving a single chromosomal rrn operon (Figure 1). Introduc-
tion of pK4-16 restored the growth rate close to the level observed in the
DrrnGADEH ptRNA strain (P = 0.00002).
For the single rrn strains to serve as genetic tools and select for
mutations in rrn, whole-genome-sequences of strains SQ37, SQ88,
SQ2203, SQ110, and SQ171were determined.Mapping of the sequence
reads confirmed correct deletion of the appropriate rrn operons, and
the density of sequence reads in SQ37, containing a single deletion, and
SQ88, containing five deletions, was evenly distributed across the
genome (Figure S4). However, in single rrn operon strains SQ2203,
SQ110 and SQ171 genomic regions were found in which the density of
sequence reads was doubled, reflecting DNA duplications (Figure S4).
The duplications always seemed to have occurred between two scar
sites. In an extension of this work, whole-genome-sequences of multi-
ple colonies of SQ110 and SQ2203 as well as negamycin-resistant mu-
tants derived therefrom (Olivier et al. 2014, McKinney et al. 2015) were
determined, and in some of these the duplication pattern was altered
(Figure 2). This observation suggests that the combination of the severe
growth defect observed upon removal of the penultimate rrn operon
(Figure 1) and the presence of six identical scar sequences spread
through the genome promote recombination events.
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